Oncology - European Medical Journal

Continue

Oncology

Filter
EMJ
31 May 2016

Promising Platelet Production Process Pioneered

MASS production of platelets is now one step closer, thanks to a team of researchers who have discovered a new method of creating platelet-producing…
EMJ
31 May 2016

Exercise Proves Key to Preventing Cancer

AN INTERNATIONAL team of researchers have compiled data from 12 different studies demonstrating the important role exercise can play in helping to…
EMJ
4 May 2016

Celyad announces oral presentation on NKR-2 T Cells Manufacturing for a First-in-Human Clinical Trial in AML and Multiple Myeloma

Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell…
EMJ
29 Apr 2016

Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer

Berlin, Germany, April 29, 2016 – Glycotope GmbH, a clinical-stage immuno-oncology company built on world-leading glyco-biology expertise, today…
EMJ
21 Apr 2016

MammaPrint Genetic Test Can Reduce Use of Post-Surgery Chemotherapy among Early-Stage Breast Cancer Patients

NEW ORLEANS — Among patients with early-stage breast cancer who were considered at high risk for disease recurrence based on clinical and biological…
EMJ
15 Apr 2016

Celyad Will Present Its NKR-2 Immuno-Oncology Clinical Program at 2016 ASCO Annual Meeting

Mont-Saint-Guibert, Belgium: Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell…
EMJ
15 Apr 2016

Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy

GENEVA, Switzerland, 15 April 2016: Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit…
EMJ
15 Apr 2016

Immunotherapy with Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma

GENEVA, Switzerland, 14 April 2016: Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and…
We’ve noticed you’re accessing
from North/South America.